Case Report: Massive Hepatocellular Carcinoma Complete Surgical Resection After Portal Vein Embolization and Multimodality Therapy
Open Access
- 29 April 2022
- journal article
- case report
- Published by Frontiers Media SA in Frontiers in Radiology
Abstract
A high proportion of massive patients with hepatocellular carcinoma (HCC) are not amenable for surgical resection at initial diagnosis, owing to insufficient future liver remnant (FLR) or an inadequate surgical margin. For such patients, portal vein embolization (PVE) is an essential approach to allow liver hypertrophy and prepare for subsequent surgery. However, the conversion resection rate of PVE only is unsatisfactory because of tumor progression while awaiting liver hypertrophy. We report here a successfully treated case of primary massive HCC, where surgical resection was completed after PVE and multimodality therapy, comprising hepatic artery infusion chemotherapy (HAIC), Lenvatinib plus Sintilimab. A pathologic complete response was achieved. This case demonstrates for the first time that combined PVE with multimodality therapy appears to be safe and effective for massive, potentially resectable HCC and can produce deep pathological remission in a primary tumor.Keywords
This publication has 22 references indexed in Scilit:
- Correction to: “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”Annals of Oncology, 2019
- Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized studyChinese Journal of Cancer, 2017
- Prognostic impact of surgical margin in patients with hepatocellular carcinomaMedicine, 2017
- Radioembolization for the treatment of hepatocellular carcinomaClinical and Molecular Hepatology, 2017
- Embolisation portale préopératoire : présent et futurBulletin du Cancer, 2017
- Associating Liver Partition and Portal Vein Ligation for Staged HepatectomyJAMA Surgery, 2015
- Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE StudyLiver International, 2015
- Sequential Transcatheter Arterial Chemoembolization and Portal Vein Embolization versus Portal Vein Embolization Only before Major Hepatectomy for Patients with Hepatocellular CarcinomaAnnals of Surgical Oncology, 2010
- Three Hundred and One Consecutive Extended Right HepatectomiesAnnals of Surgery, 2009
- Evaluation of responses to chemoembolization in patients with unresectable hepatocellular carcinomaCancer, 2003